Western Queensland PHN - COVID-19 Weekly Update

26 April 2022

Dear Practice and Pharmacy Staff,
Please see this week’s collection of updates and links for COVID Care and Vaccinations.


Winter Booster Dose in residential aged care facilities

The Australian Government Department of Health provided an update noting:

  • For some RACFs, General Practice will be the key channel for delivery of the winter booster doses.

  • Where delivery by General Practice is not possible, a Commonwealth In-reach service will be arranged in communication with the PHN

  • A COVID-19 Winter Dose Information Kit is available

  • RACF workers who meet ATAGI’s criteria of a vulnerable individual should be supported to receive a winter dose from 4 months after their booster dose.

View Information Kit for RACFs
View Fact Sheet for RACF workers


NUVAXOVID (NOVAVAX) – Expiry date changes

As noted in the recent Provider Bulletin, the Therapeutic Goods Administration (TGA) approved a shelf-life of 6 months from the date of manufacture of NUVAXOVID (Novavax), provided that approved storage conditions between 2°C to 8°C have been maintained.
Cartons and vials of Nuvaxovid were labelled with an expiry in the month/year format but continue to meet the TGA approved shelf life up to 6 months after the date of manufacture. This is reflected in the revised expiry date when expressed as a day/month/year. The changed expiry date applies to the following batch number that has been distributed:

Batch Number

Labelled Expiry Date

Date of Manufacture

Revised Expiry Date


Apr 22

22 Nov 2021

22 May 2022


Novavax stock at sites: This revised expiry date applies to all stock on site provided that approved storage conditions have been maintained.

The Department has requested that vaccinating sites please update the expiry date on any vials you have on site to reflect the revised expiry date.

The Chief Health Officer provides a Ramadan message

Dr John Gerrard has provided a message for Muslim communities about being COVID-safe during Ramadan celebrations, and promoting a statement from the Australian National Imams Council that COVID-19 vaccination does not break fasting. The message is available in English and the following languages: Urdu (اردو), Swahili (Kiswahili), Somali (Af-Soomaali), Punjabi (ਪੰਜਾਬੀ), Persian (فارسی), Arabic (عربي), Dari (دری).


Clinical guidance on COVID-19 vaccine administration errors

ATAGI has provided advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. This advice includes winter booster doses. Link to ATAGI advice.


ATAGI advice on use of sedation for COVID-19 vaccination

ATAGI provides an overview of the principles for the use of sedation as one of a range of measures to assist in the safe administration of COVID-19 vaccines. Link to ATAGI advice.

Booster doses in adolescents

Link to ATAGI statement on the use of booster doses in adolescents aged 12-15 years.

Vaccination Locations in Western Queensland

The list of Vaccination Clinics in Western Queensland is updated weekly. It includes General Practices, Pharmacies and HHS outreach clinics and is available on the WQPHN website.
Please email Melissa Williams to notify WQPHN of any change you want to your listing.


Updated forms - Queensland Health

The Go-To webpage on the Queensland Health Website

The webpage COVID-19 information for Queensland clinicians holds the latest available information to assist Queensland clinicians to respond to COVID-19.

Recently updated forms are:

For the latest state and national COVID-19 guidance view details at  WQ HealthPathways

Message from the Deputy Chief Medical Officer, Prof. Michael Kidd

In recent weeks I have discussed treating patients who are infected with COVID-19 with the COVID-19 anti-viral medications Paxlovid and Lagevrio (Molnupiravir). These medications are taken as capsules or tablets. There is information on the department’s website on oral treatments for COVID-19.

Lagevrio is currently available for prescription under the Pharmaceutical Benefits Scheme (PBS). From 1 May, Paxlovid will also become available under the PBS. Paxlovid will benefit patients with mild to moderate COVID-19, who are at risk of developing severe disease. Until then, you will need to work with your local, state, or territory health department to access Paxlovid for your patient(s).

There are currently an estimated 370,228 active cases of COVID-19 across Australia. Over 3,100 people are hospitalised with COVID-19, with 146 patients in intensive care.
So far this year, there have been more than 5 million cases of COVID-19, and 4,700 deaths reported across Australia. 

Prof Kidd notes three new items on the Department’s website:


Queensland PHNs Webinar: An approach to end-of-life care from the consumer and clinician’s perspective - Tuesday 26 April: 6.30pm to 8.00pm

General Practitioners (GPs) and general practice staff are invited to attend an upcoming webinar organised by Queensland's primary health networks (PHNs). The webinar will review a case study discussing the approach to end-of-life-care for our patients and their families during the COVID-19 pandemic.
Facilitated by Helen Mees, health consumer, this panel discussion will cover:

  • a systematic approach to end-of-life-care

  • being proactive: advance care planning and clinical care planning

  • HealthPathways to support end-of-life care in your community


  • Dr Geoff Mitchell, Partner and GP, Limestone Medical Centre Ipswich, and Emeritus Professor, School of Medicine, University of Queensland.  

  • Dr Leyton Miller, Palliative Care and Advance Care Planning Registrar, Metro South Health.

  • Prof Liz Reymond MBBS (Hons), PhD, FRACGP, FAChPM, Director, Brisbane South Palliative Care Collaborative, Director, Statewide Office of Advance Care Planning, and Deputy Director, Metro South Palliative Care Service.


WQPHN COVID-19 Response Contacts

Kathleen O’Hara, Program Manager, COVID-19 Response 
Email: Phone: 0456 001 789

Sarah Carige, Coordinator, COVID-19 Response
Email: Phone: 0417 745 342

Melissa Williams, Coordinator, COVID-19 Response
Email: Phone: 0448 999 218

Western Queensland Primary Health Network gratefully acknowledges the financial and other support from the Australian Government Department of Health


Although funding has been provided by the Australian Government, the material contained herein does not necessarily represent the views
or policies of, nor is endorsed by, the Australian Government.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Western Queensland PHN · 11 Barkly Highway RFDS Base · Mount Isa, QLD 4825 · Australia